{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:13:24Z","timestamp":1788581604060,"version":"build-2803163510"},"reference-count":60,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Helicobacter pylori (H. pylori) is the most common bacterial infection worldwide and one of the main etiological factors of chronic gastritis, peptic ulcer disease, and stomach neoplasms. The mass application of antibiotics without testing, especially during the last years of the pandemic of SARS-CoV-2, could lead to a dramatic increase in antibiotic resistance and reduced effectiveness of eradication regimens for H. pylori infection. The epidemiology of H. pylori resistance to antibiotics still has unclear mechanisms. Antibiotic policy should be intensified to optimize treatment, and regular monitoring of resistance of H. pylori in different geographical regions should be conducted. Individualized treatment according to susceptibility testing is strongly advisable, and the best treatment regimens should be selected. The mutations in the genes encoding the antibiotic target protein are significant risk factors for H. pylori resistance. Iatrogenic errors in diagnosis and prescribing treatment for the failure of H. pylori eradication are other important risk factors. The low level of awareness and compliance with the correct treatment influence the rate of H. pylori resistance. Epidemiological surveillance of antibiotic resistance and the adoption of new treatment strategies are needed. The discovery of an efficient vaccine against H. pylori could reduce the pressure of the world\u2019s growing antibiotic resistance.<\/jats:p>","DOI":"10.3390\/antibiotics12071184","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:28:06Z","timestamp":1689294486000},"page":"1184","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Epidemiology of Helicobacter pylori Resistance to Antibiotics (A Narrative Review)"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9774-5305","authenticated-orcid":false,"given":"Irena","family":"Mladenova","sequence":"first","affiliation":[{"name":"Department of Hygiene, Epidemiology, Microbiology, Parasitology and Infectious Diseases, Medical Faculty, Trakia University, 6000 Stara Zagora, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/jgh.15832","article-title":"Geospatial analysis of Helicobacter pylori infection in South Australia: Should location influence eradication therapy?","volume":"37","author":"Schubert","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17754","DOI":"10.1038\/s41598-022-21661-y","article-title":"Alarming antibiotics resistance of Helicobacter pylori from children in Southeast China over 6 years","volume":"12","author":"Shu","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1097\/CM9.0000000000002546","article-title":"Chinese national clinical practice guideline on Helicobacter pylori eradication treatment","volume":"135","author":"Zhou","year":"2022","journal-title":"Chin. Med. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1556\/030.2023.01940","article-title":"Geographic distribution of antibiotic resistance of Helicobacter pylori: A study in Bulgaria","volume":"70","author":"Boyanova","year":"2023","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Fauzia, K.A., Aftab, H., Tshibangu-Kabamba, E., Alfaray, R.I., Saruuljavkhlan, B., Cimuanga-Mukanya, A., Matsumoto, T., Subsomwong, P., Akada, J., and Miftahussurur, M. (2023). Mutations Related to Antibiotics Resistance in Helicobacter pylori Clinical Isolates from Bangladesh. Antibiotics, 12.","DOI":"10.3390\/antibiotics12020279"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e12958","DOI":"10.1111\/hel.12958","article-title":"Individualized diagnosis and eradication therapy for Helicobacter pylori infection based on gene detection of clarithromycin resistance in stool specimens: A systematic review and meta-analysis","volume":"28","author":"Ren","year":"2023","journal-title":"Helicobacter"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fcimb.2017.00168","article-title":"Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance","volume":"7","author":"Hu","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e03203-20","DOI":"10.1128\/JCM.03203-20","article-title":"Helicobacter pylori antimicrobial resistance and gene variants in high- and low-gastric-cancer-risk populations","volume":"59","author":"Mannion","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"40024","DOI":"10.57187\/smw.2023.40024","article-title":"Clarithromycin-based Helicobacter pylori eradication therapy is not associated with higher treatment failure compared with non-clarithromycin-based regimens in a tertiary referral hospital in Switzerland","volume":"153","author":"Braendli","year":"2023","journal-title":"Swiss. Med. Wkly."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e12939","DOI":"10.1111\/hel.12939","article-title":"Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea","volume":"28","author":"Lee","year":"2023","journal-title":"Helicobacter"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.14309\/ajg.0000000000002045","article-title":"Rates of Antimicrobial Resistance in Helicobacter pylori Isolates from Clinical Trial Patients across the US and Europe","volume":"118","author":"Graham","year":"2023","journal-title":"Am. J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.11604\/pamj.2022.42.144.33217","article-title":"Helicobacter pylori resistance to metronidazole and its association with virulence factors in a Moroccan population","volume":"42","author":"Imane","year":"2022","journal-title":"Pan Afr. Med. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.31557\/APJCP.2022.23.8.2755","article-title":"Comparative Study of Helicobacter pylori Resistance to Clarithromycin and Metronidazole and Its Association with Epidemiological Factors in A Moroccan Population","volume":"23","author":"Essaidi","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e15121","DOI":"10.7717\/peerj.15121","article-title":"The prevalence of clarithromycin-resistant Helicobacter pylori isolates: A systematic review and meta-analysis","volume":"11","author":"Sholeh","year":"2023","journal-title":"PeerJ"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Tran, T.T., Nguyen, A.T., Quach, D.T., Pham, D.T., Cao, N.M., Nguyen, U.T., Dang, A.N., Tran, M.A., Quach, L.H., and Tran, K.T. (2022). Emergence of amoxicillin resistance and identification of novel mutations of the pbp1A gene in Helicobacter pylori in Vietnam. BMC Microbiol., 22.","DOI":"10.1186\/s12866-022-02463-8"},{"key":"ref_16","first-page":"60","article-title":"Helicobacter pylori infection: A balance between bacteria and host","volume":"55","author":"Bucci","year":"2023","journal-title":"Rev. Argent Microbiol."},{"key":"ref_17","first-page":"331","article-title":"Risk factor, diagnosis, and current treatment of H. pylori Infection in Indonesia: A Literature Review","volume":"53","author":"Iman","year":"2021","journal-title":"Acta Med. Indones."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e12932","DOI":"10.1111\/hel.12932","article-title":"Antibiotic resistance patterns of Helicobacter pylori in North Israel\u2014A six-year study","volume":"27","author":"Azrad","year":"2022","journal-title":"Helicobacter"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.arcmed.2022.08.010","article-title":"Prevalence of Primary Multidrug-resistant Helicobacter pylori in Children: A Systematic Review and Meta-analysis","volume":"53","author":"Karbalaei","year":"2022","journal-title":"Arch. Med. Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Antunes, R., Oleastro, M., Nogueira, J.P., and Lopes, A.I. (2023). Time trend prevalence of Helicobacter pylori infection and endoscopic findings in symptomatic children in Portugal: A retrospective study based on three time points in 2009, 2014, and 2019. Helicobacter, e12963.","DOI":"10.1111\/hel.12963"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.14309\/ajg.0000000000001828","article-title":"Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: A Systematic Review and Meta-Analysis","volume":"117","author":"Ho","year":"2022","journal-title":"Am. J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Srisuphanunt, M., Wilairatana, P., Kooltheat, N., Duangchan, T., Katzenmeier, G., and Rose, J.B. (2023). Molecular Mechanisms of Antibiotic Resistance and Novel Treatment Strategies for Helicobacter pylori Infections. Trop. Med. Infect. Dis., 8.","DOI":"10.3390\/tropicalmed8030163"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e0390322","DOI":"10.1128\/spectrum.03903-22","article-title":"RdxA Diversity and Mutations Associated with Metronidazole Resistance of Helicobacter pylori","volume":"11","author":"Gong","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e12956","DOI":"10.1111\/hel.12956","article-title":"New regimens as first-line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial","volume":"28","author":"Zhang","year":"2023","journal-title":"Helicobacter"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e12952","DOI":"10.1111\/hel.12952","article-title":"Critical appraisal of international guidelines for the management of Helicobacter pylori infection in case of dyspepsia","volume":"28","author":"Collin","year":"2023","journal-title":"Helicobacter"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.34172\/mejdd.2022.259","article-title":"Addition of Nitazoxanide to Standard Clarithromycin Based Triple Therapy for 2 Weeks Effectively Eradicates Treatment-Naive Helicobacter pylori Infection. A Single Centre prospective, open-label study","volume":"14","author":"Jha","year":"2022","journal-title":"Middle East J. Dig. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Dieye, Y., Nguer, C.M., Thiam, F., Diouara, A.A.M., and Fall, C. (2022). Recombinant Helicobacter pylori Vaccine Delivery Vehicle: A Promising Tool to Treat Infections and Combat Antimicrobial Resistance. Antibiotics, 11.","DOI":"10.3390\/antibiotics11121701"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Feng, X., Bian, L., Zhang, Y., Li, Q., Xu, Y., She, Q., Yan, C., Lu, G., and Wu, J. (2023). Antibiotic Resistance of Helicobacter pylori and Related Risk Factors in Yangzhou, China: A Cross-Sectional Study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12030816"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e12954","DOI":"10.1111\/hel.12954","article-title":"Helicobacter pylori treatment knowledge, access and barriers: A cross-sectional study","volume":"28","author":"Bailey","year":"2023","journal-title":"Helicobacter"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Alarc\u00f3n-Mill\u00e1n, J., Bonilla-Delgado, J., Fern\u00e1ndez-Tilapa, G., Nieto-Vel\u00e1zquez, N.G., Sierra-Mart\u00ednez, M., Alvarado-Castro, V.M., and Cort\u00e9s-Malag\u00f3n, E.M. (2023). Helicobacter pylori Virulence Factors and Clarithromycin Resistance-Associated Mutations in Mexican Patients. Pathogens, 12.","DOI":"10.3390\/pathogens12020234"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Ari\u00f1o-P\u00e9rez, I., Mart\u00ednez-Dom\u00ednguez, S.J., Alfaro Almajano, E., Carrera-Lasfuentes, P., and Lanas, \u00c1. (2023). Mistakes in the diagnosis and treatment of Helicobacter pylori infection in daily clinical practice. Helicobacter, e12957.","DOI":"10.1111\/hel.12957"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Yusuf, K., Sampath, V., and Umar, S. (2023). Bacterial Infections and Cancer: Exploring This Association And Its Implications for Cancer Patients. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043110"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"110052","DOI":"10.1016\/j.ijfoodmicro.2022.110052","article-title":"Clarithromycin-, and metronidazole-resistant Helicobacter pylori isolated from raw and ready-to-eat meat in Mansoura, Egypt","volume":"387","author":"Maghrabia","year":"2023","journal-title":"Int. J. Food Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1121947","DOI":"10.3389\/fcimb.2023.1121947","article-title":"Focusing on Helicobacter pylori infection in the elderly","volume":"13","author":"Gong","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e12974","DOI":"10.1111\/hel.12974","article-title":"Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori","volume":"28","author":"Kwon","year":"2023","journal-title":"Helicobacter"},{"key":"ref_36","first-page":"224","article-title":"Antimicrobial Resistance of Helicobacter pylori among Low-resource Chinese Minorities","volume":"29","author":"Yang","year":"2023","journal-title":"Altern Ther. Health Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/14787210.2023.2181788","article-title":"Iatrogenic factors of Helicobacter pylori eradication failure: Lessons from the frontline","volume":"21","author":"Xie","year":"2023","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1136\/gutjnl-2021-324032","article-title":"European Helicobacter pylori Antimicrobial Susceptibility Testing Working Group. Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community","volume":"70","author":"Megraud","year":"2021","journal-title":"Gut"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"17562848231170941","DOI":"10.1177\/17562848231170941","article-title":"Rescue therapy for refractory Helicobacter pylori infection: Current status and future concepts","volume":"16","author":"Wang","year":"2023","journal-title":"Therap. Adv. Gastroenterol."},{"key":"ref_40","first-page":"79","article-title":"Factors associated with failure of Helicobacter pylori eradication","volume":"45","author":"Gu","year":"2020","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e1184","DOI":"10.1002\/mbo3.1184","article-title":"Primary antibiotic resistance of Helicobacter pylori isolates is twofold more frequent in HIV-positive than HIV-negative individuals: A descriptive observational study","volume":"10","author":"Nkuize","year":"2021","journal-title":"Microbiologyopen"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/hiv.13083","article-title":"Failure to eradicate Helicobacter pylori infection is more frequent among HIV-positive patients","volume":"22","author":"Nkuize","year":"2021","journal-title":"HIV Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1093\/jac\/dkaa315","article-title":"High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: A municipality-wide, multicentre, prospective cohort study","volume":"75","author":"Lyu","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jgar.2020.06.007","article-title":"High rates of clarithromycin and levofloxacin resistance of Helicobacter pylori in patients with chronic gastritis in the south east area of Vietnam","volume":"22","author":"Dang","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5152\/tjg.2020.18631","article-title":"Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey","volume":"31","author":"Erkut","year":"2020","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/jgh.14774","article-title":"Association between parental history of Helicobacter pylori treatment failure and treatment failure in the offspring","volume":"34","author":"Deguchi","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cmi.2019.06.007","article-title":"Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018","volume":"26","author":"Bluemel","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jgar.2019.05.015","article-title":"Refractory Helicobacter pylori gastritis: The hidden predictors of resistance","volume":"19","author":"Hanafy","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/jgh.14625","article-title":"Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication","volume":"34","author":"Lee","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jgh3.12081","article-title":"The effect of vitamin D deficiency on eradication rates of Helicobacter pylori infection","volume":"2","author":"Hemida","year":"2018","journal-title":"JGH Open"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jgar.2018.06.016","article-title":"Antimicrobial resistance among Helicobacter pylori isolates in Alaska, 2000\u20132016","volume":"15","author":"Mosites","year":"2018","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_52","first-page":"747","article-title":"Primary and Secondary Antibiotic Resistance of Helicobacter pylori in Israeli Children and Adolescents","volume":"19","author":"Kori","year":"2017","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.humpath.2016.09.013","article-title":"Increased plasmacytic differentiation in gastric mucosa-associated lymphoid tissue lymphomas: Helicobacter pylori eradication response and IgG4+ plasma cell association","volume":"59","author":"Park","year":"2017","journal-title":"Hum. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Nkuize, M., De Wit, S., Muls, V., Delforge, M., Miendje Deyi, V.Y., Cadi\u00e8re, G.B., and Buset, M. (2015). HIV-Helicobacter pylori Co-Infection: Antibiotic Resistance, Prevalence, and Risk Factors. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0145119"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"White, B., Winte, M., DeSipio, J., and Phadtare, S. (2022). Clinical Factors Implicated in Antibiotic Resistance in Helicobacter pylori Patients. Microorganisms, 10.","DOI":"10.3390\/microorganisms10020322"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-136-1-200201010-00008","article-title":"Risk factors for Helicobacter pylori resistance in the United States: The surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993\u20131999","volume":"136","author":"Meyer","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3201\/eid1006.030744","article-title":"Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States","volume":"10","author":"Duck","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1099\/jmm.0.003855-0","article-title":"Evaluation of clinical and socio-demographic risk factors for antibacterial resistance of Helicobacter pylori in Bulgaria","volume":"58","author":"Boyanova","year":"2009","journal-title":"J. Med. Microbiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1099\/jmm.0.035568-0","article-title":"Numerous risk factors for Helicobacter pylori antibiotic resistance revealed by extended anamnesis: A Bulgarian study","volume":"61","author":"Boyanova","year":"2012","journal-title":"J. Med. Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastrohep.2019.05.002","article-title":"Primary antimicrobial resistance rates and prevalence of Helicobacter pylori infection in the north of Spain. A 13-year retrospective study","volume":"42","author":"Morilla","year":"2019","journal-title":"Gastroenterol. Hepatol."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/7\/1184\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:12:14Z","timestamp":1760127134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/7\/1184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":60,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["antibiotics12071184"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics12071184","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]}}}